159 related articles for article (PubMed ID: 32166534)
1. Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial.
Iseas S; Roca EL; O'Connor JM; Eleta M; Sanchez-Luceros A; Di Leo D; Tinelli M; Fara ML; Spitzer E; Demarco IA; Ripoll GV; Pifano M; Garona J; Alonso DF
Invest New Drugs; 2020 Oct; 38(5):1580-1587. PubMed ID: 32166534
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease.
Gill JC; Ottum M; Schwartz B
J Pediatr; 2002 May; 140(5):595-9. PubMed ID: 12032528
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history.
Sánchez-Luceros A; Meschengieser SS; Woods AI; Chuit R; Turdó K; Blanco A; Lazzari MA
Thromb Haemost; 2010 Nov; 104(5):984-9. PubMed ID: 20886181
[TBL] [Abstract][Full Text] [Related]
4. Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries.
Sharma R; Stein D
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e371-5. PubMed ID: 24942016
[TBL] [Abstract][Full Text] [Related]
5. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.
Arshad F; Stoof SC; Leebeek FW; Ruitenbeek K; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Kruip MJ; Lisman T
Liver Int; 2015 Jul; 35(7):1809-15. PubMed ID: 25522671
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin (DDAVP) and hemostasis.
Lethagen S
Ann Hematol; 1994 Oct; 69(4):173-80. PubMed ID: 7948303
[TBL] [Abstract][Full Text] [Related]
7. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A
Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368
[TBL] [Abstract][Full Text] [Related]
8. Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.
Mason JA; Robertson JD; McCosker J; Williams BA; Brown SA
Haemophilia; 2016 Sep; 22(5):700-5. PubMed ID: 27385253
[TBL] [Abstract][Full Text] [Related]
9. Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease.
Santoro C; Hsu F; Dimichele DM
Haemophilia; 2012 Mar; 18(2):200-4. PubMed ID: 21771208
[TBL] [Abstract][Full Text] [Related]
10. High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.
Leissinger C; Becton D; Cornell C; Cox Gill J
Haemophilia; 2001 May; 7(3):258-66. PubMed ID: 11380629
[TBL] [Abstract][Full Text] [Related]
11. DDAVP-induced hyponatremia in young children.
Das P; Carcao M; Hitzler J
J Pediatr Hematol Oncol; 2005 Jun; 27(6):330-2. PubMed ID: 15956888
[TBL] [Abstract][Full Text] [Related]
12. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.
Jilma B; Paulinska P; Jilma-Stohlawetz P; Gilbert JC; Hutabarat R; Knöbl P
Thromb Haemost; 2010 Sep; 104(3):563-70. PubMed ID: 20589313
[TBL] [Abstract][Full Text] [Related]
13. Desmopressin--a nontransfusional form of prevention of postextractive bleeding in some patients with von Willebrand's type I disease. Case report.
Rahnama M; Tomaszewski T; Swiatkowski W
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):150-3. PubMed ID: 12898917
[TBL] [Abstract][Full Text] [Related]
14. Common management issues in pediatric patients with mild bleeding disorders.
O'Brien SH
Semin Thromb Hemost; 2012 Oct; 38(7):720-6. PubMed ID: 23034827
[TBL] [Abstract][Full Text] [Related]
15. Intranasal desmopressin (Octim): a safe and efficacious treatment option for children with bleeding disorders.
Khair K; Baker K; Mathias M; Burgess C; Liesner R
Haemophilia; 2007 Sep; 13(5):548-51. PubMed ID: 17880442
[TBL] [Abstract][Full Text] [Related]
16. Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin.
Trummer A; Haarmeijer B; Werwitzke S; Wermes C; Ganser A; Budde U; Tiede A
Haemophilia; 2013 Mar; 19(2):236-41. PubMed ID: 23051555
[TBL] [Abstract][Full Text] [Related]
17. A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients.
Weinberg RS; Grecco MO; Ferro GS; Seigelshifer DJ; Perroni NV; Terrier FJ; Sánchez-Luceros A; Maronna E; Sánchez-Marull R; Frahm I; Guthmann MD; Di Leo D; Spitzer E; Ciccia GN; Garona J; Pifano M; Torbidoni AV; Gomez DE; Ripoll GV; Gomez RE; Demarco IA; Alonso DF
Springerplus; 2015; 4():428. PubMed ID: 26306290
[TBL] [Abstract][Full Text] [Related]
18. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.
Rose EH; Aledort LM
Ann Intern Med; 1991 Apr; 114(7):563-8. PubMed ID: 1900403
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin effects on bleeding during functional endoscopic sinus surgery on patients with chronic rhinosinusitis.
Hajimohamadi F; Hosseini J; Heidari F; Alvandi S; Bastaninezhad S; Ghabasiah A; Tajdini A
Am J Otolaryngol; 2021; 42(5):103024. PubMed ID: 33838357
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin to prevent and treat bleeding in pregnant women with an inherited bleeding disorder: a systematic literature review.
Al Arashi W; Romano LGR; Leebeek FWG; Kruip MJHA; van Galen KPM; Turan O; Kadir RA; Cnossen MH;
J Thromb Haemost; 2024 Jan; 22(1):126-139. PubMed ID: 37778511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
